Summary 5-Amino-1MQ is an orally active small molecule designed to support fat metabolism, energy utilization, and body composition by targeting cellular pathways involved in energy storage and expenditure
Although significant progress has been made in the research on the pathogenesis of neurodegenerative diseases such as Alzheimers disease, Parkinsons disease, amyotrophic lateral sclerosis and Huntingtons disease, and many drugs have found neuroprotective effects in cells and animal models, but there is still no drug that can produce clinical changes significantly in the pathogenesis
Common symptoms include tiredness, lethargy, feeling faint, becoming breathless
Nov 1 2007;110(9):2110-2118
One caveat was that participants in the mB12/LDFA and BH4 studies had significantly worse markers of glutathione metabolism and chronic oxidative stress at baseline, respectively